berobenatide   Click here for help

GtoPdb Ligand ID: 14570

Synonyms: MET-097 | MET-097i | MET097 | PF'3944 | PF-08653944 | PF08653944
Compound class: Peptide
Comment: Berobenatide (PF-08653944, formerly MET097) is an ultra-long-acting GLP-1 receptor agonist. Structurally, berobenatide is an exendin-4 analogue that is modified for extended circulating half-life (~15.5 days).
No information available.
Summary of Clinical Use Click here for help
Berobenatide (PF-08653944) was progressed as a clinical lead for the treatment of type 2 diabetes and for weight management in obese patients. It is proopsed as a once-weekly or once-monthly injectable drug.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT07595549 A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity Phase 3 Interventional Pfizer The VESPER-6 study
NCT07575932 A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) Phase 2 Interventional Pfizer The SOLIS-1 study
NCT07400653 A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) Phase 3 Interventional Pfizer The VESPER-5 study
NCT07311850 Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity Phase 3 Interventional Pfizer The VESPER-4 study